Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;194(1-2):169-77.
doi: 10.1016/j.jviromet.2013.08.012. Epub 2013 Aug 29.

Inferring viral population structures using heteroduplex mobility and DNA sequence analyses

Affiliations

Inferring viral population structures using heteroduplex mobility and DNA sequence analyses

Raj Shankarappa et al. J Virol Methods. 2013 Dec.

Abstract

Heteroduplex mobility (HMA) and tracking assays (HTA) are used to assess genetic relationships between DNA molecules. While distinguishing relationships between clonal or nearly clonal molecules is relatively straightforward, inferring population structures is more complex. To address this issue, HIV-1 quasispecies with varying levels of diversity were studied using both HTA and DNA sequencing. Viral diversity estimates and the temporal features of virus evolution were found to be generally concordant between HTA and DNA sequencing. In addition, the distribution of pairwise differences and the rates of virus divergence were similar between the two methods. These findings support the use of HTA to characterize variant populations of DNA and strengthen previous inferences concerning the evolution of HIV-1 over the course of infection.

Keywords: DNA sequencing; HIV-1; Heteroduplex mobility assay; Heteroduplex tracking assay; Viral diversity; Viral evolution.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Assessment of genetic changes in HIV-1 over the course of infection using HTA and DNA sequence data
The gel images of the heteroduplexes formed between variants present at each time point and heteroduplex tracking probes derived from early, founder sequences (panel A), or late (final time point) sequences (panel D) are shown for each individual. Rox dye labeled molecular size markers were incorporated into each HTA and their sizes in basepairs are indicated on the left. Genetic distances estimated using heteroduplex mobilities (HTA-distance) are plotted in panels B and E for the probes derived from the founder and final sequences, respectively. Panels C and F illustrate the profile of pairwise DNA distances between sequences sampled at each time point and the founder (panel C) or final (panel F) sequence populations. For DNA distances, each pairwise distance value is plotted as an open diamond with the average values connected by a line. X-axes show the years following seroconversion (not plotted to scale).
Figure 2
Figure 2. Comparison of genetic distances estimated using HTA and DNA sequences according to the individual, time following infection, and the type of probe used in HTA experiments
Panel A illustrates the genetic distances plotted with respect to time following seroconversion, separately for each subject. Panel B shows the scatter plots of HTA- versus DNA-distance data, derived using the founder sequence (upper graph) and the final sequence probes (lower graph).
Figure 3
Figure 3. Temporal features in the evolution of HIV-1 assessed using HTA and DNA sequence data
Panel A illustrates intra-time point diversity and the HTA using probes as indicated at the top and driver sequences from each sample. The upper and middle sections of panel A illustrate the HTA distances and the source heteroduplexes, respectively, and the bottom section illustrates the DNA distances. Each pairwise DNA distance is depicted as an open diamond with a line connecting the average values. The purple colored open bar spanning all three sections of Panel A identifies the sample from which the probe sequences were derived. Panel B illustrates heteroduplexes formed between the labeled cloned probe DNA sequence from V14 (2.9 years post-seroconversion) and V15 (3.4 years post-seroconversion) and the driver virus population in samples over the course of infection. Highlighted lanes identify the sample from which cloned probes were derived.

Similar articles

References

    1. Abraha A, Troyer RM, Quinones-Mateu ME, Arts EJ. Methods to determine HIV-1 ex vivo fitness. Methods in molecular biology. 2005;304:355–68. - PubMed
    1. Agwale SM, Robbins KE, Odama L, Saekhou A, Zeh C, Edubio A, Njoku OM, Sani-Gwarzo N, Gboun MF, Gao F, Reitz M, Hone D, Folks TM, Pieniazek D, Wambebe C, Kalish ML. Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping. J Clin Microbiol. 2001;39:2110–4. - PMC - PubMed
    1. Apetrei C, Collin G, Diculencu D, Ajaka IL, Farfara I, Panzaru C, Coman G, Duca M, Brun-Vezinet F, Simon F. The isolation and subtyping of the human immunodeficiency virus (HIV) from children in Moldova. The evidence for subtype F. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 1995;99:124–8. - PubMed
    1. Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russell KL, Carr JK. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr. 2002;29:422–6. - PubMed
    1. Bachmann MH, Delwart EL, Shpaer EG, Lingenfelter P, Singal R, Mullins JI. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization AIDS research and human retroviruses. 1994;10:1345–53. - PubMed

Publication types

LinkOut - more resources